Showing results (471-480 of 728) with videos related to
Sort By:
Pageof 73
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|June 23, 2015
Is the relationship between sedentary behaviour and cardiometabolic health in adolescents independent of dietary intake? A systematic reviewE Fletcher, R Leech, S A McNaughton, et al.Alimentary Pharmacology & Therapeutics|September 9, 2015
The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapyS L Shah, B E Lacy, J K DiBaise, et al.Lancet (London, England)|June 9, 1990
64,000 Mr autoantibodies as predictors of insulin-dependent diabetesM A Atkinson, N K Maclaren, D W Scharp, et al.Diabetologia|December 1, 1977
Ninhydrin inhibition of glucose-induced insulin releaseM L McDaniel, C E Roth, C J Fink, et al.Surgery|January 1, 1975
Transplantation of islets of Langerhans in diabetic rhesus monkeysD W Scharp, J J Murphy, W T Newton, et al.Chest|October 10, 2001
The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response studyM D Crowell, E N Zayat, B E Lacy, et al.Scandinavian Journal of Gastroenterology|June 29, 2006
Physicians' attitudes and practices in the evaluation and treatment of irritable bowel syndromeBrian E Lacy, Justin Rosemore, Douglas Robertson, et al.Alimentary Pharmacology & Therapeutics|June 4, 2013
Functional dyspepsia: the economic impact to patientsB E Lacy, K T Weiser, A T Kennedy, et al.Metabolism: Clinical and Experimental|October 1, 1978
Elevated levels of pancreatic polypeptide in obese-hyperglycemic miceR L Gingerich, D J Gersell, M H Greider, et al.Neurogastroenterology and Motility|August 17, 2022
Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double-blind, placebo-controlled phase 2 trialBrian E Lacy, Jennifer King, Denise Shortino, et al.Pageof 73